Rate My Professor Lisa Hall

Hall leads a multidisciplinary research program centered on healthcare-associated infection prevention and control, antimicrobial stewardship, implementation science, and economic evaluation. Her pragmatic research assesses the effectiveness, cost-effectiveness, feasibility, and sustainability of interventions, emphasizing evidence translation into policy and practice. As Chief Investigator, she has secured over $19 million in grants since 2013, including NHMRC-funded projects such as the REACH trial evaluating environmental cleaning bundles in hospitals, the National Centre for Infections in Cancer improving surveillance and prevention for cancer patients, and the GAPS Trial on reducing antibiotic prescribing in primary care. She has published more than 150 peer-reviewed papers, including recent contributions like "Preventing bloodstream infections through effective surveillance, AUDIT and FEEDBACK: evaluation of a 20-year hospital program using a TYPE I hybrid design" (2026, Antimicrobial Resistance and Infection Control), "Applications and reporting of causal inference modelling in infectious disease studies: a systematic review" (2026, Infectious Disease Modelling), and "The INTERACT Study - Infection Prevention and Surveillance Practice in the care of the Australasian Cancer and Transplant Population" (2025, American Journal of Infection Control). Hall served as a technical expert on the Australian Commission on Safety and Quality in Healthcare's Healthcare Associated Infection Advisory Committee from 2009 to 2024 and holds positions as Associate Editor for Infection Control & Hospital Epidemiology and editorial board member for Antimicrobial Resistance & Infection Control.